175 related articles for article (PubMed ID: 19908045)
1. [Highly differentiated liver tumors: recent developments and their diagnostic application].
Schirmacher P; Longerich T
Pathologe; 2009 Dec; 30 Suppl 2():200-6. PubMed ID: 19908045
[TBL] [Abstract][Full Text] [Related]
2. [Recent developments in biopsy diagnosis of early and undefined liver tumors].
Longerich T; Schirmacher P
Z Gastroenterol; 2009 Jan; 47(1):30-6. PubMed ID: 19156590
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management.
Shanbhogue AK; Prasad SR; Takahashi N; Vikram R; Sahani DV
Radiology; 2011 Mar; 258(3):673-93. PubMed ID: 21339346
[TBL] [Abstract][Full Text] [Related]
4. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
5. Pathological diagnosis of benign hepatocellular nodular lesions based on the new World Health Organization classification.
Kondo F; Fukusato T; Kudo M
Oncology; 2014; 87 Suppl 1():37-49. PubMed ID: 25427732
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
[TBL] [Abstract][Full Text] [Related]
8. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.
Bioulac-Sage P; Balabaud C; Bedossa P; Scoazec JY; Chiche L; Dhillon AP; Ferrell L; Paradis V; Roskams T; Vilgrain V; Wanless IR; Zucman-Rossi J;
J Hepatol; 2007 Mar; 46(3):521-7. PubMed ID: 17239484
[No Abstract] [Full Text] [Related]
9. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
10. Multiple β-catenin mutations in hepatocellular lesions arising in Abernethy malformation.
Sorkin T; Strautnieks S; Foskett P; Peddu P; Thompson RJ; Heaton N; Quaglia A
Hum Pathol; 2016 Jul; 53():153-8. PubMed ID: 27038679
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
12. Evaluating Liver Biopsies with Well-Differentiated Hepatocellular Lesions.
Umetsu SE; Kakar S
Surg Pathol Clin; 2023 Sep; 16(3):581-598. PubMed ID: 37536890
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma.
Choi WT; Kakar S
Gastroenterol Clin North Am; 2017 Jun; 46(2):311-325. PubMed ID: 28506367
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
Choi WT; Ramachandran R; Kakar S
Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
[TBL] [Abstract][Full Text] [Related]
16. [Hepatocellular tumours in noncirrhotic liver tissue].
Goltz D; Fischer HP
Pathologe; 2015 Nov; 36(6):597-606; quiz 607-8. PubMed ID: 26496997
[TBL] [Abstract][Full Text] [Related]
17. [Highly differentiated hepatocellular tumors. Concepts, criteria, and differential diagnosis].
Schrimacher P; Prange W; Dries V; Dienes HP
Pathologe; 2001 Nov; 22(6):407-16. PubMed ID: 11766640
[TBL] [Abstract][Full Text] [Related]
18. [Overview: liver tumors].
Graziadei I
Wien Med Wochenschr; 2013 Mar; 163(5-6):109-12. PubMed ID: 23361850
[TBL] [Abstract][Full Text] [Related]
19. Atypical Hepatocellular Neoplasms: Review of Clinical, Morphologic, Immunohistochemical, Molecular, and Cytogenetic Features.
Choi WT; Kakar S
Adv Anat Pathol; 2018 Jul; 25(4):254-262. PubMed ID: 29649004
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.
Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F
J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
